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Abstract
Background: The unique cell wall of bacteria of the suborder Corynebacterineae is essential for the growth and survival of
significant human pathogens including Mycobacterium tuberculosis and Mycobacterium leprae. Drug resistance in
mycobacteria is an increasingly common development, making identification of new antimicrobials a priority. Recent
studies have revealed potent anti-mycobacterial compounds, the benzothiazinones and dinitrobenzamides, active against
DprE1, a subunit of decaprenylphosphoribose 29 epimerase which forms decaprenylphosphoryl arabinose, the arabinose
donor for mycobacterial cell wall biosynthesis. Despite the exploitation of Mycobacterium smegmatis in the identification of
DprE1 as the target of these new antimicrobials and its use in the exploration of mechanisms of resistance, the essentiality
of DprE1 in this species has never been examined. Indeed, direct experimental evidence of the essentiality of DprE1 has not
been obtained in any species of mycobacterium.
Methodology/Principal Findings: In this study we constructed a conditional gene knockout strain targeting the ortholog of
dprE1 in M. smegmatis, MSMEG_6382. Disruption of the chromosomal copy of MSMEG_6382 was only possible in the
presence of a plasmid-encoded copy of MSMEG_6382. Curing of this ‘‘rescue’’ plasmid from the bacterial population resulted
in a cessation of growth, demonstrating gene essentiality.
Conclusions/Significance: This study provides the first direct experimental evidence for the essentiality of DprE1 in
mycobacteria. The essentiality of DprE1 in M. smegmatis, combined with its conservation in all sequenced mycobacterial
genomes, suggests that decaprenylphosphoryl arabinose synthesis is essential in all mycobacteria. Our findings indicate a
lack of redundancy in decaprenylphosphoryl arabinose synthesis in M. smegmatis, despite the relatively large coding
capacity of this species, and suggest that no alternative arabinose donors for cell wall biosynthesis exist. Overall, this study
further validates DprE1 as a promising target for new anti-mycobacterial drugs.
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Introduction
The genus Mycobacterium contains several species of medical
importance, most notably the re-emerging human pathogen
Mycobacterium tuberculosis that causes nearly two million deaths each
year, the most by any single infectious agent. Despite the
availability of a vaccine, the number of infected individuals
worldwide continues to increase, as does the prevalence of drug-
resistant forms of M. tuberculosis [1]. A key virulence factor of
Mycobacterium is the highly hydrophobic cell wall that is common
to bacteria of the suborder Corynebacterineae and forms the
interface between host and pathogen (Fig. 1A). The cell wall core
is composed of peptidoglycan covalently linked to arabinogalactan
esterified with mycolic acids, forming the mycolyl-arabinogalac-
tan-peptidoglycan or ‘mAGP’ complex [2]. It also contains a series
of free glycolipids including trehalose monomycolates (TMM),
trehalose dimycolates (TDM), phosphatidylinositol mannosides
(PIM) and lipoarabinomannans (LAM) that facilitate interactions
with host cells [3]. The essentiality of the core for mycobacterial
growth and survival means that enzymes involved in synthesis of
core structures are considered excellent targets for drug develop-
ment [4]. Indeed, most current front-line TB drugs target some
aspect of cell wall synthesis [5].
The emergence of drug-resistant strains of M. tuberculosis [5,6] is
a disturbing development that highlights the need for new anti-
mycobacterial compounds, particularly those with the capacity to
kill persistent bacteria. Recent studies have described two classes of
potent compounds with specific activities against mycobacteria.
Dinitrobenzamide derivatives (DNB), originally identified in a
high-throughput, fluorescence microscopy-based screen of a
library of small molecules, showed potent anti-mycobacterial
efficacy including activity against extensively drug resistant (XDR)
M. tuberculosis strains, and little significant host cell toxicity [7].
Most significantly, these compounds could inhibit M. tuberculosis
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mycobacterial cell wall as the target for inhibition, specifically the
arabinan layers of arabinogalactan and LAM, and revealed that
the arabinose donor for these layers, decaprenylphosphoryl
arabinose (DPA), was not being produced from its substrate,
decaprenylphosphoryl ribose (DPR, Fig. 1B). This finding strongly
suggested that DNBs were targeting the heteromeric decaprenyl-
phosphoribose 29 epimerase encoded by the Rv3790 (dprE1) and
Rv3791 (dprE2) genes of M. tuberculosis [8]. This was further
supported by the finding that strains carrying a C387G mutation
in DprE1 were DNB-resistant [7]. While DprE2 is also necessary
for the epimerisation reaction, there is evidence of redundancy at
this step [9], making DprE2 a less attractive target for drug
intervention.
The potential importance of DprE1 as a drug target was further
reinforced by studies on a separate set of nitro-compounds related
to DNBs. Synthesis of a series of sulfur-containing heterocycles led
to the identification of nitro-benzothiazinones (BTZ), a class of
compounds with potent anti-mycobacterial activities [10]. These
compounds were found to have very low MICs for M. tuberculosis
and the non-pathogenic model species Mycobacterium smegmatis,
were more potent against intracellular bacilli than front line TB
drugs isoniazid and rifampin, relatively non-toxic [11] and active
against multidrug-resistant clinical isolates of M. tuberculosis [12].
To identify the BTZ target(s), two genetic approaches were
employed. The first used cosmids and subcloning to identify the
DNA region responsible for BTZ resistance in M. smegmatis while
the second involved identification and characterization of BTZ-
resistant strains of M. smegmatis, M. bovis BCG, and M. tuberculosis.
Both approaches revealed the respective DprE1 orthologs as the
target. In addition, membrane preparations from wild-type M.
smegmatis were used to show that the epimerisation reaction was
inhibited by BTZ while membranes from resistant strains were
resistant to such inhibition [11]. M. smegmatis was also exploited to
identify a novel mechanism of resistance to BTZ involving
overexpression of the nitroreductase NfnB [13].
Despite the exploitation of M. smegmatis in the identification of
DprE1 as the target for BTZ and in exploring mechanisms of BTZ
resistance, the essentiality of the putative DprE1 ortholog in this
species has never been examined. Indeed, to our knowledge, the
essentiality of DprE1 has not been experimentally investigated in
any species of Mycobacterium or Corynebacterium. The Coryne-
bacterium glutamicum ortholog (NCgl0187) could not be deleted by
Meniche and colleagues [9] and the M. tuberculosis ortholog
(Rv3790) is thought to be essential based on a lack of insertions in
transposon mutagenesis experiments [14], however, in both cases,
direct experimental evidence of essentiality is lacking. In this study
we demonstrate through direct experimental approaches that
MSMEG_6382 is essential for the growth of M. smegmatis.W e
show that the MSMEG_6382 gene can only be disrupted in the
presence of a second copy which, when removed, leads to a
cessation of growth in vitro. Our findings indicate a lack of
redundancy in DPA synthesis in M. smegmatis, despite the
organism’s relatively large coding capacity, and suggest that no
alternative arabinose donors exist in this species. Overall, this
study further validates DprE1 as a candidate for intervention by
new generations of anti-mycobacterial drugs.
Results and Discussion
MSMEG_6382 is the ortholog of DprE1 in M. smegmatis
MSMEG_6382 is 84% identical/91% similar to Rv3790
(designated DprE1 [11]) from M. tuberculosis and 82% identical/
91% similar to ML0109 from M. leprae (Fig. 2). Orthologs can also
be clearly identified in Mycobacterium avium (MAV_0232, 75%/
84%), Mycobacterium bovis (Mb3819, 84%/91%), Corynebacterium
diphtheriae (DIP1062, 72%/82%), C. glutamicum (NCgl0187, 68%/
80%) Nocardia farcinica (nfa1970, 73%/85%) and Rhodococcus spp.
Figure 1. The Mycobacterial cell wall and pathway for DPA biosynthesis. A. The mycobacterial cell wall is a multilayered structure
containing many components unique to these and closely related bacteria, including phosphatidylinositol mannosides (PIM), lipoarabinomannans
(LAM), trehalose monomycolates (TMM), trehalose dimycolates (TDM) mycolic acids and arabinogalactan. The biosynthetic pathways for these unique
components are a rich source of potential drug targets. Arabinose sugars are shown in orange. B. Decaprenylphosphoryl arabinose (DPA) is formed
by the epimerization of decaprenylphosphoryl ribose (DPR) by DprE1 (Rv3790) and DprE2 (Rv3791). DPA serves as an arabinose donor in cell wall
biosynthesis, contributing to arabinogalactan and LAM assembly (orange arrows).
doi:10.1371/journal.pone.0016869.g001
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Rv3790, Fig. 2) that results in BTZ resistance when mutated is
conserved in all of these species with the exception of M. avium
which is naturally BTZ-resistant [11].
Construction of a conditional knockout of MSMEG_6382
(DprE1) in M. smegmatis
To gain insights into the importance of MSMEG_6382, we
attempted to disrupt the MSMEG_6382 gene by insertional
inactivation with a drug resistance cassette. Despite several
attempts, we were unable to generate this mutant, a result similar
to that reported by Meniche et al who were unable to disrupt the C.
glutamicum ortholog, NCgl0187 [9]. While the inability to generate
a viable mutant raises the possibility that the enzyme might be
essential to the organism, it is not proof of essentiality since other
technical issues may be responsible. To investigate this further, we
employed a genetic approach to assess the essentiality of
MSMEG_6382 (see Materials and Methods for details) that had
been used previously to assess the essentiality of the cell wall
lipase/thioesterase, Rv3802c [15].
This strategy used homologous recombination at the
MSMEG_6382 locus to disrupt the chromosomal copy of
MSMEG_6382 in the presence of a ‘‘rescue’’ plasmid carrying
an intact copy of the same gene (Fig. 3). Briefly, the gene and
flanking DNA was PCR amplified and cloned into an Escherichia
coli vector followed by insertion of a DNA fragment carrying the
aphA3 gene, encoding kanamycin resistance, into MSMEG_6382.
This fragment was then subcloned into pPR27, a vector with a
temperature-sensitive origin of replication for M. smegmatis,a
gentamycin resistance gene and a gene encoding sucrose
sensitivity, sacB (Fig. 3A). This plasmid was introduced into M.
smegmatis mc
2155 and a single crossover strain (Fig. 3B) was
selected on kanamycin plates and confirmed by Southern
hybridisation (Fig. 4, lane 3). The single crossover strain carried
both an intact and a disrupted copy of MSMEG_6382 (Fig. 3B).
This single crossover strain was then used to initiate a second
crossover event in the presence of a rescue plasmid carrying an
intact MSMEG_6382 gene (Fig. 3C). The rescue plasmid was
created by PCR cloning MSMEG_6382 into the vector pCG76,
which carries a temperature sensitive origin of replication for M.
smegmatis and a streptomycin resistance gene [16]. Following
electroporation of the rescue plasmid into the single crossover
strain, allelic replacement of the chromosomal MSMEG_6382
with the disrupted copy was successfully achieved, giving rise to a
‘‘conditional knockout’’ strain that carried a disrupted chromo-
somal copy of MSMEG_6382 and an intact copy on the rescue
plasmid (Fig. 3C). The conditional knockout was confirmed by
Southern hybridisation (Fig. 4, lane 4), with the rescue plasmid
forming a strong band due to the presence of multiple copies. The
conditional knockout strain was designated 6382CKO.
MSMEG_6382 (DprE1) is essential for the growth of
M. smegmatis
If MSMEG_6382 is essential, then 6382CKO should be reliant
on the rescue plasmid for growth. The plasmid has a temperature-
sensitive origin of replication and can replicate at 30uC but not at
42uCandiscuredfrom the bacterial cellsoverseveralgenerations of
growth at 42uC [16]. To determine whether is 6382CKO is reliant
on the rescue plasmid, the strain was grown to saturation at 30uC
then diluted into fresh LB broth pre-warmed at 30uCa n d4 2 uC.
Samples were taken regularly from the two cultures over several
days and serial dilutions prepared for plating on LB+Kn plates to
determine the number of viable bacteria as colony forming units
(cfu) per ml. The 6382CKO strain continued to grow in the 30uC
Figure 2. DprE1 alignment. Homologs from M. leprae (ML0109), M. tuberculosis (Rv3790) and M. smegmatis (MSMEG_6382) were aligned using
CLUSTALW [25]. Residues that are completely conserved are reverse shaded while similar residues are indicated in grey. The putative FAD-binding
domain is shown by a solid line. The conserved cysteine residue that is altered in BTZ-resistant mycobacteria [11] is indicated by an asterix.
doi:10.1371/journal.pone.0016869.g002
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growth continued at 42uC for just 2 days and then declined over the
next 4 days. This ‘‘lag’’ is not unexpected because several
generations must be completed in order for the rescue plasmid to
be cured from the population. A control culture of wild-type M.
smegmatis mc
2155 carrying the kanamycin resistance plasmid
pMV261 grew well at both temperatures, and at a similar rate to
6382CKO at30uC,showingthatthecessationof6382CKO growth
at 42uC was not simply due to the temperature change. These data
show that MSMEG_6382 is essential for the growth of M. smegmatis
in LB broth, the first time that a DprE1 ortholog has been shown to
be essential in a mycobacterial species.
To determine whether MSMEG_6382 is essential for growth in
other media as well, we attempted to repeat the growth curve
experiment in Middlebrook 7H9 broth, a medium used for
pathogenic mycobacteria but also suitable for M. smegmatis.
Surprisingly, 6382CKO failed to grow in this medium, even at
30uC, while wild-type M. smegmatis grew well. Preparing a
saturated pre-culture in LB broth followed by dilution into 7H9
also resulted in no growth. This result suggests that the 6382CKO
strain has a moderate cell wall defect even at 30uC which renders
it non-viable in particular media. Middlebrook 7H9 has a lower
salt concentration than LB broth which may lead to lysis of
enfeebled strains. Since 6382CKO contains multiple copies of the
MSMEG_6382 gene, we propose that overexpression of
MSMEG_6382 is occurring in this strain resulting in aberrant
cell wall synthesis that lead to an inability to grow in media with
low osmotic pressure, such as Middlebrook 7H9.
Figure 3. Genetic strategy for conditional disruption of MSMEG_6382.A . The recombination plasmid pPKC72 contained a cloned copy of
MSMEG_6382 interrupted by a non-polar kanamycin resistance cassette (MSMEG_6382::aphA3), a gentamycin resistance marker (Gm
r), a temperature-
sensitive replication origin for M. smegmatis (oriMs (ts)), a replication origin for E. coli (oriEc) and a counterselectable marker encoding sucrose
sensitivity (sacB). The construct was introduced into M. smegmatis at the permissive temperature (30uC). Integration of the plasmid by a single
crossover at the position indicated was detected by growing the cells at the non-permissive temperature (42uC) in the presence of kanamycin. B.
Genetic map of the single crossover, showing key restriction sites and fragments. C. Culturing the single crossover strain containing a rescue plasmid
encoding MSMEG_6382 gave rise to a disrupted copy of MSMEG_6382 in the chromosome, producing the conditional knockout (6382CKO). Since the
disruption of MSMEG_6382 coincided with the loss of the sacB gene, the conditional knockout strain could be selected on sucrose plates. Double lines
indicate chromosomal DNA, single lines indicate plasmid DNA. Restriction fragments hybridising to the MSMEG_6382-specific probe are shown in
kilobases (kb).
doi:10.1371/journal.pone.0016869.g003
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that 6382CKO grew as well as wild-type on solid Middlebrook
7H10 agar. To investigate whether MSMEG_6382 is essential for
growth on 7H10 we incubated 6382CKO at 30uC and 42uC along
with a wild-type control strain. As shown in Figure 6, the control
strain grew at both temperatures while 6382CKO failed to grow at
42uC. Some growth was visible in the primary streak (Fig. 6D) but
this was expected because several generations of growth at 42uC
are required to cure the rescue plasmid, as described above.
Overall, we were able to conclude that the MSMEG_6382 gene is
essential for M. smegmatis growth under at least two different
culture conditions.
To determine the structural consequences of a loss of
MSMEG_6382 on M. smegmatis, we examined the 6382CKO
strain, cultured at 42uC for 5 days on LB agar, by scanning and
transmission electron microscopy. Surprisingly, the cells were
found to be intact (data not shown), suggesting a bacteriostatic
rather than bacteriolytic effect. This is in contrast to a conditional
knockout of another cell wall biosynthesis enzyme, Rv3802c,
which had a dramatic loss of cellular integrity at 42uC [15]. It is
also inconsistent with the finding that exposure of M. smegmatis and
M. tuberculosis to one BTZ derivative, BTZ043, resulted in a
swelling of the poles of the cells followed by lysis [11]. If BTZ043
kills M. smegmatis by inhibiting MSMEG_6382, we would predict
that drug treated cells and our conditional knockout cured of the
rescue plasmid would look the same. However, the experimental
conditions of the two studies are significantly different and
Makarov et al used extremely high concentrations of the drug to
induce pole swelling and lysis. Also, although the reasons for the
discrepancy are unclear, it is possible that extending our growth
curve beyond 5 days might reveal cell lysis. Unfortunately, the
strong selective pressure leads to the appearance of revertents after
5 days at 42uC that overgrow the culture, so we were unable to
extend the experiment beyond a 5 day period. We have isolated
such revertents from CKO6382 and they fail to grow on Sm at
30uCo r4 2 uC, suggesting loss of the rescue plasmid. Revertents
are also readily isolated from other conditional knockouts we have
constructed, including a published strain [15]. The most likely
explanation is that the intact copy of the gene on the rescue
plasmid recombines into the genome under strong selective
pressure to restore viability at 42uC.
Figure 4. Conditional disruption of MSMEG_6382. Southern blot of
genomic DNA digested with HindIII/NotI/XbaI. Lane 1, DNA molecular
weight DNA markers of the sizes indicated (kilobases, kb); lane 2, wild-
type M. smegmatis mc
2155; lane 3, single crossover strain used to derive
the conditional knockout; lane 4, conditional knockout of MSMEG_6382,
designated 6382CKO.
doi:10.1371/journal.pone.0016869.g004
Figure 5. MSMEG_6382 is essential for growth of M. smegmatis in LB broth. 6382CKO was cultured at 30uC in LB containing Kn and Sm. At
saturation, 5 ml was used to inoculate 200 ml of LB/Kn medium that had been prewarmed at the permissive (30uC N) or non-permissive (42uC &)
temperature. Incubation was continued at the two temperatures and both cultures were sampled regularly with serial dilutions plated on LB plates
containing Kn to determine colony forming units (CFUs) per ml. A wild-type M. smegmatis mc
2155 strain containing the kanamycin resistance plasmid
pMV261 was included as a control (30uC m,4 2 uC .). Unbroken lines represent the 6382CKO strain while broken lines represent the wild type
(pMV261) control strain. These data represent means of triplicate samples 6 standard deviation and are representative of three independent
experiments.
doi:10.1371/journal.pone.0016869.g005
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M. smegmatis
M. smegmatis is often used as a model for pathogenic
mycobacteria due to its relatively fast growth rate and well-
defined genetic systems. As a saprophytic bacterium with the
capacity to adapt to a range of conditions, it possesses a large
genome of 7.0 Mb encoding 6,829 genes. By comparison, the M.
tuberculosis H37Rv genome is 4.4 Mb (3,918 genes) [17] while the
genome of the obligate pathogen Mycobacterium leprae comprises just
3.3 Mb (2,720 genes) [18]. The relatively large codon capacity of
M. smegmatis increases the potential for redundancy in cell wall
biosynthetic (and other) pathways. However, our findings suggest
that there is no redundancy in the DprE1 step in M. smegmatis.
Based on this finding, we predict that the epimerisation reaction
will be essential in all mycobacteria and corynebacteria, making
DprE1 inhibitors effective against a range of problematic
pathogens. The second component of the epimerisation complex,
DrpE2, shows less potential as a drug target because disruption of
the C. glutamicum ortholog is possible due to compensation by a
functionally equivalent enzyme. Enzymes that could compensate
for the DprE2 of M. tuberculosis (Rv3791) have also been described
[9], although Rv3791 has been predicted to be essential in M.
tuberculosis [14]. In addition, we have successfully disrupted the
dprE2 ortholog of M. smegmatis (data not shown), suggesting
redundancy in this organism as well. Studies on this dprE2
(MSMEG_6385) mutant are currently in progress.
No alternative arabinose donors for cell wall biosynthesis
in M. smegmatis
The essentiality of DprE1 in M. smegmatis also suggests that there
are no alternative arabinose donors in this species that can
compensate for a lack of DPA. If present, such donors would be
expected to restore viability to a dprE1 mutant. A possible
alternative arabinose donor has been described in M. smegmatis
(Wolucka, 2008). This compound, which contains an activated D-
arabinose that could theoretically serve as a donor, was identified
as a partially saturated b-D-arabinosyl-1-monophospho-octahy-
droheptaprenol (Wolucka and Hoffmann, 1994). It is possible that
this species could be also formed by the DprE1/DprE2
epimerization complex but ribosylated derivatives of C35-octahy-
droheptaprenyl phosphate have never been described (Wolucka,
2008), making this an unlikely possibility. The biosynthetic
pathway and biological role(s) of this molecule remain unknown.
DprE1 as a ‘‘magic’’ mycobacterial drug target
In this study we have employed a genetic approach to provide
further evidence of the essentiality of DprE1 in mycobacteria.
Although two new classes of antibiotics highly specific for
mycobacteria seem to target this enzyme [7,11], and indirect
evidence of essentiality had been reported in C. glutamicum and
M. tuberculosis [9,14], direct experimental evidence of essentiality
has never been presented before. The essentiality of DprE1 in M.
smegmatis, combined with its conservation in all sequenced
mycobacterial genomes, suggests that DPA synthesis is essential
in all mycobacteria and not subject to redundancy. DprE1 has
been described as a ‘‘magic’’ drug target [19] and our findings are
in full agreement with this assessment.
Materials and Methods
Growth and manipulation of E. coli and M. smegmatis
Bacteria were routinely cultured at 30uC, 37uCo r4 2 uC in Luria
Burtani (LB) medium or Middlebrook medium (7H9 broth or
7H10 agar, Difco) supplemented with kanamycin (Kn, 20 mg/ml),
streptomycin (Sm, 20 mg/ml), ampicillin (Ap, 100 mg/ml) and
sucrose (10% w/v), as appropriate. Tween-80 was added to 0.05%
(v/v) to reduce clumping in mycobacterial liquid cultures.
Figure 6. MSMEG_6382 is essential for growth of M. smegmatis on Middlebrook agar. The conditional knockout strain 6382CKO was
cultured at 30uC on Middlebrook 7H10 agar containing Kn and Sm, then subcultured onto Middlebrook 7H10 agar containing Kn at 30uC and 42uC
and examined for growth. Wild-type M. smegmatis mc
2155 control strain cultured at 30uC( A) and 42uC( B) on Middlebrook 7H10 agar without
antibiotics; 6382CKO strain cultured at 30uC( C) and 42uC( D) on Middlebrook 7H10 agar containing Kn.
doi:10.1371/journal.pone.0016869.g006
DprE1 Is Essential in Mycobacterium smegmatis
PLoS ONE | www.plosone.org 6 February 2011 | Volume 6 | Issue 2 | e16869Competent M. smegmatis cells were prepared as described [20] and
electroporated using a Biorad Gene Pulser with the following
settings: 2.5 kV, 1000V,2 5mF.
DNA Manipulations
Polymerase chain reactions were performed using Proofstart
DNA Polymerase (Qiagen) according to the manufacturer’s
instructions. Reactions consisted of a hot-start (95uC, 5 min)
followed by 35 cycles of denaturation (95uC, 1 min), annealing
(55uC, 1 min) and extension (72uC, 2 min). Restriction enzymes
and T4 DNA polymerase were from Roche or New England
Biolabs. Genomic DNA was prepared from mycobacteria as
described [21]. Southern blots [22] were performed using
digoxygenin-labelled probes (Roche) according to manufacturer’s
instructions.
Construction and analysis of a conditional knockout of
MSMEG_6382
Rv3790 and flanking DNA was PCR amplified from M.
smegmatis mc
2155 genomic DNA as a 2 kb fragment using primers
A( 5 9- GATCAAGCTTACGCCCTCGATCGTCCTG-39) and B
(59- TGCAGCGGCCGCCAGCGCGTGCAGCGAG -39), di-
gested at the underlined restriction sites for HindIII and NotI,
and cloned into HindIII-NotI-digested pUC18 [23]. A 1.9 kb non-
polar kanamycin resistance cassette carrying the aphA3 gene was
then inserted at a unique EcoRV site within MSMEG_6382.
Finally, the 3.9 kb HindIII-NotI fragment containing MSME-
G_6382::aphA3 was transferred to BamHI-digested pPR27 [24],
following T4 polymerase treatment of both insert and vector,
creating the final recombination plasmid, pPKC72.
To generate single crossovers, pPKC72 was introduced into M.
smegmatis mc
2155 by electroporation and selecting kanamycin
resistant clones at 30uC. A 10 ml LB broth containing kanamycin
was inoculated with culture single colony and grown for five days
at 30uC to saturation. Serial dilutions were plated onto LB+Kn
plates at 42uC and incubated for four days to select for potential
single crossovers. Colonies were screened for incorporation of
pPKC72 into the chromosome by growing 10 ml LB/Kn cultures
to saturation at 42uC, extracting genomic DNA, digesting with
HindIII/NotI/XbaI and performing a Southern hybridization
with a probe specific for MSMEG_6382. A single crossover,
designated Myc51, was selected for further analysis.
To derive a double crossover (a conditional knockout) a rescue
plasmid containing MSMEG_6382 carried on a 2.0 kb XbaI
fragment cloned into the temperature-sensitive plasmid pCG76
[16] was introduced into Myc51 by electroporation. The XbaI
fragment did not contain sequences upstream of MSMEG_6382 so
gene expression is reliant on vector promoters. Transformants
were selected on LB+Kn+Sm plates at 30uC and a single colony
was grown to saturation LB+Kn+Sm broth at 30uC. Serial
dilutions were plated on LB+Kn+Sm plates containing sucrose
and incubated at 30uC. Potential conditional knockout clones were
grown in 10 ml LB/Kan/Sm to saturation followed by genomic
DNA extraction, digestion with HindIII/NotI/XbaI and Southern
blotting using a MSMEG_6382-specific probe. A confirmed
conditional knockout strain was designated 6382CKO.
To determine growth curves, 6382CKO and control strains
were cultured in 10 ml LB/kan at 30uC for 3 days, then 5 ml was
added to 200 ml of LB/Kan that had been pre-warmed to 30uC
or 42uC. The cultures were sampled daily and serial dilutions
plated onto LB/Kan at 30uC. Following 5 days incubation,
colonies were counted to determine the number of colony forming
units per ml.
Acknowledgments
We wish to thank Svetozar Kovacevic and David Lea-Smith for helpful
discussions, Brigitte Gicquel for providing pPR27 and Helen Billman-
Jacobe for providing pCG76.
Author Contributions
Conceived and designed the experiments: PKC RLC. Performed the
experiments: PKC RB. Analyzed the data: PKC RLC. Contributed
reagents/materials/analysis tools: RB. Wrote the paper: PKC RLC.
References
1. World Health Organization (2009) WHO Report 2009: Global Tuberculosis
Control - epidemiology, strategy, financing.
2. Daffe M, Draper P (1998) The envelope layers of mycobacteria with reference to
their pathogenicity. Adv Microb Physiol 39: 131–203.
3. Brennan PJ (2003) Structure, function, and biogenesis of the cell wall of
Mycobacterium tuberculosis. Tuberculosis (Edinb) 83: 91–97.
4. Brennan PJ, Crick DC (2007) The cell-wall core of Mycobacterium tuberculosis
in the context of drug discovery. Curr Top Med Chem 7: 475–488.
5. Riccardi G, Pasca MR, Buroni S (2009) Mycobacterium tuberculosis: drug
resistance and future perspectives. Future Microbiol 4: 597–614.
6. Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, et al. (2006)
Global incidence of multidrug-resistant tuberculosis. J Infect Dis 194: 479–
485.
7. Christophe T, Jackson M, Jeon HK, Fenistein D, Contreras-Dominguez M,
et al. (2009) High content screening identifies decaprenyl-phosphoribose 29
epimerase as a target for intracellular antimycobacterial inhibitors. PLoS Pathog
5: e1000645.
8. Mikusova K, Huang H, Yagi T, Holsters M, Vereecke D, et al. (2005)
Decaprenylphosphoryl arabinofuranose, the donor of the D-arabinofuranosyl
residues of mycobacterial arabinan, is formed via a two-step epimerization of
decaprenylphosphoryl ribose. J Bacteriol 187: 8020–8025.
9. Meniche X, de Sousa-d’Auria C, Van-der-Rest B, Bhamidi S, Huc E, et al.
(2008) Partial redundancy in the synthesis of the D-arabinose incorporated in the
cell wall arabinan of Corynebacterineae. Microbiology 154: 2315–2326.
10. Makarov V, Riabova OB, Yuschenko A, Urlyapova N, Daudova A, et al. (2006)
Synthesis and antileprosy activity of some dialkyldithiocarbamates. J Antimicrob
Chemother 57: 1134–1138.
11. Makarov V, Manina G, Mikusova K, Mollmann U, Ryabova O, et al. (2009)
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan
synthesis. Science 324: 801–804.
12. Pasca MR, Degiacomi G, Ribeiro AL, Zara F, De Mori P, et al. (2010) Clinical
isolates of Mycobacterium tuberculosis in four European hospitals are uniformly
susceptible to benzothiazinones. Antimicrob Agents Chemother 54: 1616–
1618.
13. Manina G, Bellinzoni M, Pasca MR, Neres J, Milano A, et al. (2010) Biological
and structural characterization of the Mycobacterium smegmatis nitroreductase
NfnB, and its role in benzothiazinone resistance. Mol Microbiol 77: 1172–
1185.
14. Sassetti CM, Boyd DH, Rubin EJ (2003) Genes required for mycobacterial
growth defined by high density mutagenesis. Mol Microbiol 48: 77–84.
15. Crellin PK, Vivian JP, Scoble J, Chow FM, West NP, et al. (2010)
Tetrahydrolipstatin inhibition, functional analyses and three dimensional
structure of a lipase essential for mycobacterial viability. J Biol Chem 285:
30050–30060.
16. Guilhot C, Gicquel B, Martin C (1992) Temperature-sensitive mutants of the
Mycobacterium plasmid pAL5000. FEMS Microbiol Lett 77: 181–186.
17. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, et al. (1998) Deciphering
the biology of Mycobacterium tuberculosis from the complete genome sequence.
Nature 393: 537–544.
18. Cole ST, Eiglmeier K, Parkhill J, James KD, Thomson NR, et al. (2001) Massive
gene decay in the leprosy bacillus. Nature 409: 1007–1011.
19. Manina G, Pasca MR, Buroni S, De Rossi E, Riccardi G (2010) Decaprenylpho-
sphoryl-beta-D-Ribose 29-Epimerase from Mycobacterium tuberculosis is a
Magic Drug Target. Curr Med Chem 17: 3099–3108.
20. Jacobs WR, Kalpana GV, Cirrillo JD, Pascopella L, Snapper SB, et al. (1991)
Genetic systems for mycobacteria. Methods in Enzymology 204: 537–
555.
21. Anderberg RJ, Strachan JA, Cangelosi GA (1995) Purification of DNA from
Mycobacterium species without sonication or phenol. Biotechniques 18:
217–219.
DprE1 Is Essential in Mycobacterium smegmatis
PLoS ONE | www.plosone.org 7 February 2011 | Volume 6 | Issue 2 | e1686922. Southern EM (1974) An improved method for transferring nucleotides from
electrophoresis strips to thin layers of ion-exchange cellulose. Anal Biochem 62:
317–318.
23. Vieira J, Messing J (1982) The pUC plasmids, an M13mp7-derived system for
insertion mutagenesis and sequencing with synthetic universal primers. Gene 19:
259–268.
24. Pelicic V, Jackson M, Reyrat JM, Jacobs WR, Jr., Gicquel B, et al. (1997)
Efficient allelic exchange and transposon mutagenesis in Mycobacterium
tuberculosis. Proc Natl Acad Sci U S A 94: 10955–10960.
25. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007)
Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947–2948.
DprE1 Is Essential in Mycobacterium smegmatis
PLoS ONE | www.plosone.org 8 February 2011 | Volume 6 | Issue 2 | e16869